title: [Biologics in asthma: what's new?].
abstract: Biologic therapies such as monoclonal antibodies are currently being developed in the field of asthma. The molecules mentioned in this article, for the majority still under development, are expected to treat certain severe asthma subgroups in a more optimal way in the near future.
authors: Buss G
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D001688:Biological Products / Q000627:therapeutic use*; D006801:Humans
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D001688:Biological Products; C434107:mepolizumab